Sci-Tech News Today
SEE OTHER BRANDS

The latest news on science and technology

Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on May 8, 2025

UbiVac CEO Participates in Cancer Vaccine Panel at SynBioBeta & Wilson Sonsini Investment Forum

UbiVac CEO Participates in Cancer Vaccine Panel at SynBioBeta & Wilson Sonsini Investment Forum

AI will accelerate discovery, but the breakthrough is off‑the‑shelf vaccines targeting shared Dark‑Genome drivers—paired with nextgen immunotherapy combinations PALO ALTO AND SAN JOSE, CA, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- At SynBioBeta, …

Kymanox® Announces Low Volume Manufacturing Capabilities Supporting Human Clinical Studies

Kymanox® Announces Low Volume Manufacturing Capabilities Supporting Human Clinical Studies

The company strengthens its end-to-end service offerings with GMP-compliant manufacturing for medical devices and device constituents of combination products KING OF PRUSSIA, PA, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Kymanox®, a leading …

Koss Corporation Reports Third Quarter Results

Koss Corporation Reports Third Quarter Results

MILWAUKEE, May 08, 2025 (GLOBE NEWSWIRE) -- Koss Corporation (NASDAQ: KOSS) (the “Company”), the U.S. based high-fidelity headphone company, has reported its results for the third quarter ended March 31, 2025. Net sales for the three months ended March 31, …

Draganfly Announces First Quarter Results of 2025

Draganfly Announces First Quarter Results of 2025

Vancouver, BC., May 08, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce its first quarter …

Entrée Resources Announces First Quarter 2025 Results

Entrée Resources Announces First Quarter 2025 Results

VANCOUVER, British Columbia, May 08, 2025 (GLOBE NEWSWIRE) -- Entrée Resources Ltd. (TSX:ETG; OTCQB:ERLFF – the “Company” or “Entrée”) has today filed its interim financial results for the first quarter ended March 31, 2025. All numbers are in U.S. dollars …

NuVista Energy Ltd. Announces Strong First Quarter 2025 Results and Significant Progress on Our Shareholder Return Strategy

NuVista Energy Ltd. Announces Strong First Quarter 2025 Results and Significant Progress on Our Shareholder Return Strategy

CALGARY, Alberta, May 08, 2025 (GLOBE NEWSWIRE) -- NuVista Energy Ltd. ("NuVista" or the "Company") (TSX: NVA) is pleased to announce strong financial and operating results for the three months ended March 31, 2025, and to provide an update on our …

Tarsus to Participate in Upcoming Investor Conferences

Tarsus to Participate in Upcoming Investor Conferences

IRVINE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced that management plans to participate in the following upcoming investor conferences: Bank of America Securities 2025 Health Care Conference on …

Total Energy Services Inc. Announces Q1 2025 Results

Total Energy Services Inc. Announces Q1 2025 Results

CALGARY, Alberta, May 08, 2025 (GLOBE NEWSWIRE) -- Total Energy Services Inc. (“Total Energy” or the “Company”) (TSX:TOT) announces its consolidated financial results for the three months ended March 31, 2025. Financial Highlights ($000’s except per share …

FLINT Announces First Quarter 2025 Financial Results

FLINT Announces First Quarter 2025 Financial Results

Reports Adjusted EBITDAS of $5.1 million, representing a 61% improvement from prior year CALGARY, Alberta, May 08, 2025 (GLOBE NEWSWIRE) -- FLINT Corp. (“FLINT” or the "Company") (TSX: FLNT) today announced its results for the three months ended March 31, …

Vital Battery Metals Announces Acquisition of Corvo Uranium Project & Closing of Financing

Vital Battery Metals Announces Acquisition of Corvo Uranium Project & Closing of Financing

Highlights: More than 29 km of exploration strike length along three strong NE-SW magnetic low trends coinciding with EM conductors and cross-cutting faults, providing highly prospective shallow drill targets. Uranium mineralization is present along a …

Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering

Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering

Hopewell, New Jersey, May 08, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally …

Innospec Reports First Quarter 2025 Financial Results

Innospec Reports First Quarter 2025 Financial Results

Balanced results considering market volatility Excellent growth in Fuels Specialties offsetting lower results in Performance Chemicals and Oilfield Services $28.3 million cash generated from operations; Net cash improves to $299.8 million Dividend …

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights

- Sharpened product candidate focus on its next-generation ADC portfolio, following strategic review and pipeline reprioritization - - Promising preclinical results with STRO-004 and dual-payload ADC, as well as STRO-006 programs presented at AACR 2025 and …

BioSyent Schedules First Quarter Earnings Release for May 15, 2025

BioSyent Schedules First Quarter Earnings Release for May 15, 2025

MISSISSAUGA, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2025 on Thursday, May 15, 2025 after market hours. A presentation …

Galecto Reports First Quarter 2025 Operating and Financial Results

Galecto Reports First Quarter 2025 Operating and Financial Results

BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced its operating and financial results for the quarter …

Montauk Renewables Announces First Quarter 2025 Results

Montauk Renewables Announces First Quarter 2025 Results

PITTSBURGH, May 08, 2025 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. (“Montauk” or “the Company”) (NASDAQ: MNTK), a renewable energy company specializing in the management, recovery, and conversion of biogas into renewable natural gas (“RNG”), today …

U.S. Energy Corp. Announces First Quarter 2025 Results Conference Call Date

U.S. Energy Corp. Announces First Quarter 2025 Results Conference Call Date

HOUSTON, May 08, 2025 (GLOBE NEWSWIRE) -- U.S. Energy Corporation (NASDAQ: USEG, “U.S. Energy” or the “Company”), a growth-focused energy company engaged in the development and operation of high-quality producing energy and industrial gas assets, today …

Theriva Biologics Announces Closing of $7.5 Million Public Offering

Theriva Biologics Announces Closing of $7.5 Million Public Offering

ROCKVILLE, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, …

EnGarde® body armor Partners with TacSource to Expand Distribution in Australia and New Zealand

EnGarde® body armor Partners with TacSource to Expand Distribution in Australia and New Zealand

AMSTERDAM, NH, NETHERLANDS, May 8, 2025 /⁨EINPresswire.com⁩/ -- EnGarde® body armor, a global leader in advanced ballistic protection solutions, is pleased to announce a new partnership with TacSource Group, a premier tactical gear supplier in Australia …

Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights

Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights

On track for first patient dosing of SER-252 in Phase 1b clinical trial in advanced Parkinson’s disease in Q4 2025 Strengthened balance sheet with recent financing Advancing innovative POZ Platform across multiple therapeutic modalities Two new seasoned …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service